Latest News Releases

Updates every hour. Last Updated: 28-Jun-2025 01:10 ET (28-Jun-2025 05:10 GMT/UTC)

6-Jan-2025

Extended Paxlovid may help some people with long COVID

University of California - San Francisco
Peer-Reviewed Publication

An extended course of Paxlovid appears to help some patients with long Covid, according to a case series by UC San Francisco researchers that suggests this treatment option holds promise for some of those struggling with debilitating symptoms. 

Journal

Communications Medicine

3-Jan-2025

Johns Hopkins APL modeling tool affirms critical role of testing in pandemic response

Johns Hopkins University Applied Physics Laboratory
Peer-Reviewed Publication

APL has contributed to a new study in The Lancet Public Health that found public-private partnerships to develop, produce and distribute COVID-19 diagnostic tests saved approximately 1.4 million lives and prevented an estimated 7 million patient hospitalizations in the U.S. during the pandemic.

Journal

The Lancet Public Health

1-Jan-2025

System to auto-detect new variants will inform better response to future infectious disease outbreaks

University of Cambridge
Peer-Reviewed Publication

Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis.

Journal

Nature

Funder

European Research Council

30-Dec-2024

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

Johns Hopkins Medicine
Peer-Reviewed Publication

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function. 

Journal

Journal of the American Medical Association

Funder

COVID Protection After Transplant Data Coordinating Center, NIH/National Institute of Allergy and Infectious Diseases, Immune Tolerance Network at the Benaroya Research Institute at the Virginia Mason Medical Center